Sensient Technologies Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction MU Q1 2026 Earnings Strong EPS Beat Drives 19 Stock Surge WSFS Q1 2026 Earnings Strong EPS Beat Driven by Core Banking Strength Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline ELS Q1 2026 Earnings EPS Beats Estimates by 117 Stock Rises Slightly ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending